4
Changes in Ownership
Eledon Pharmaceuticals, Inc. Filed Acc 0001209191-23-006324
Options or other derivatives
- Chief Executive Officer acquired 453,600 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Gros David-Alexandre C Chief Executive Officer | 2023-02-01 | Grant or award · Stock Option (right to buy) | +300,000 | 300,000 | D | ||
| Gros David-Alexandre C Chief Executive Officer | 2023-02-01 | Grant or award · Stock Option (right to buy) | +153,600 | 153,600 | D | ||
Loading xslF345X03/doc4.xml…